3M paid rising dividends for 66 years, then cut in 2024 after the Solventum spinoff. See MMM's dividend history, new streak, risks, and safety outlook.
3M paid its shareholders a dividend without interruption for more than a century — and raised it for 66 straight years, longer than almost any company alive. Then, in 2024, it did the unthinkable: after spinning off its healthcare arm Solventum, 3M cut the payout roughly in half and walked out of the dividend kings list and dividend aristocrats list in one stroke. What's left is a very different story — a smaller, safer dividend that has now been raised two years running.
| Paying dividends | Without interruption for more than 100 years |
| Old streak | 66 consecutive annual raises, ended by the 2024 cut |
| New streak | Raises in 2025 and 2026 — two years and counting |
| Status | Former Dividend King and Aristocrat; no longer either |
| Payment months | March, June, September, December |
| Payout target | Roughly 40% of adjusted free cash flow, set at the 2024 reset |
Since the 2026 raise, the quarterly payout is $0.78 — $3.12 per share annually, a yield of roughly 2% at recent prices.
| Year | Milestone |
|---|---|
| 1902 | Founded as Minnesota Mining and Manufacturing in Two Harbors, MN |
| 1950s | Start of what becomes a 66-year streak of annual increases |
| 2018–2023 | PFAS and Combat Arms earplug lawsuits balloon into multibillion-dollar settlements |
| April 2024 | Spins off healthcare unit Solventum |
| May 2024 | Cuts the quarterly dividend from $1.51 to $0.70 — the streak ends |
| 2025–2026 | Raises resume: to $0.73, then $0.78 per quarter |
Solventum — the healthcare business — generated a large share of 3M's steadiest cash flow. Once it left, the old $1.51 quarterly dividend would have consumed an uncomfortable share of what remained, and management chose a clean reset over a slow squeeze.
3M agreed to pay up to about $10.3 billion to US public water systems over PFAS "forever chemicals" and roughly $6 billion to settle Combat Arms earplug claims — payouts stretching over years. A dividend pinned at 40% of adjusted free cash flow leaves room to service both.
In its final years the streak was maintained with token penny raises while the payout ratio climbed. The cut was painful for income investors, but it traded a fragile record for a fundable one.
The realistic downside: small raises for a long time. The 2026 increase of about 7% was encouraging, but at a ~40% free-cash-flow payout the dividend itself is well covered — the open question is growth, not survival.
At a roughly 2% yield, a $10,000 position generates about $200 a year. What the number doesn't show:
3M is a turnaround income holding: a modest, well-covered dividend with a rebuilt foundation — and none of the streak pedigree it used to sell.
Every major broker offers MMM with fractional shares and free reinvestment — compare platforms, or see the companies whose streaks never broke on the dividend kings list.
Not anymore. 3M's 66-year streak of annual increases ended in 2024, when it cut the dividend roughly in half after spinning off its healthcare business, Solventum. That cost it both Dividend King and Dividend Aristocrat status. The company has raised the dividend in 2025 and 2026, so a new streak is two years old.
3M pays dividends quarterly, typically in March, June, September, and December. Since the 2024 reset, the annual increase has been announced in early February alongside fourth-quarter earnings.
Safer than it has been in years — precisely because it was cut. Management reset the payout to roughly 40% of adjusted free cash flow in 2024, a comfortable level even with 3M's large PFAS and earplug legal settlements. The risk today is slow growth, not another cut.
Every top broker we review offers MMM with $0 commissions, fractional shares, and free dividend reinvestment.